Back to Journals » Clinical Ophthalmology » Volume 6

Is age-related macular degeneration a problem in Ibadan, Sub-Saharan Africa?

Authors Oluleye T

Received 19 October 2011

Accepted for publication 12 December 2011

Published 11 April 2012 Volume 2012:6 Pages 561—564


Review by Single anonymous peer review

Peer reviewer comments 2

Tunji Sunday Oluleye
Retina and Vitreous Unit, Department of Ophthalmology, University College Hospital, Ibadan, Nigeria, West Africa

Background: Age-related macular degeneration (AMD) is considered uncommon in black populations including those of Sub-Saharan Africa. The aim of this review was to determine the pattern of presentation of AMD in our hospital located in Ibadan, the largest city in Sub-Saharan Africa.
Methods: A retrospective review of all cases with AMD presenting to the Eye and Retinal Clinic of the University College Hospital, Ibadan, West Africa was undertaken between October 2007 and September 2010.
Results: In the 3 years reviewed, 768 retinal cases were seen in the hospital, 101 (14%) of which were diagnosed with AMD. The peak age was 60–79 years. The male to female ratio was approximately 2:3. More males presented with the advanced form of dry AMD than females (odds ratio = 2.33). However, more females had advanced wet AMD than males (odds ratio = 1.85). Wet AMD was seen in 40 cases (40%).
Conclusion: The review determined that, as AMD is not uncommon and wet AMD is relatively more common in our hospital than has been reported previously, this is probably true of Ibadan in general.

Keywords: age-related maculopathy, choroidal neovascular membrane, retinal, vitreoretinal, drusen

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]